摘要
目的通过客观评价肝硬化门脉高压性胃病临床治疗现状,寻找改善肝硬化门脉高压性胃病患者临床指征的治疗方案。方法以随机法选择本院2013年7月至2015年7月接收的40例肝硬化门脉高压性胃病患者(实验组),应用普萘洛尔治疗;同期选择40例肝硬化门脉高压性胃病患者(对照组),应用常规疗法,在对所有入选患者临床指征深入观察的基础上,客观对比各项临床数据。结果本研究入选对象中,实验组入选患者有效率90.00%,而对照组是60.00%,2组疗效对比有差距(P<0.05)。结论对于肝硬化门脉高压性胃病患者,予以普萘洛尔治疗效果突出,已成为提升患者有效率以及生活水平的重要手段,可推广。
Objective To evaluate the clinical treatment status of cirrhosis and portal hypertensive gastropothy, for getting the treatment scheme of improving clinical indications of patients with cirrhosis and portal hypertensive gastropothy. Methods 40 patients with cirrhosis and portal hypertensive gastropothy treated in our hospital from July 2013 to July 2015 were selected randomly as the experiment group, and were treated with propranolol. And 40 cases with cirrhosis and portal hypertensive gastropothy were selected as the control group, and were treated with the conventional therapy. Based on observing the clinical signs of the selected patients, the clinical data of the patients was compared. Results For the selected patients, the total effective rate of the experiment group was 90.00%, and that of the control group was 60.00%. The difference between two groups was evident（P〈0.05）. Conclusion Applying propranolol to treat the patients with cirrhosis and portal hypertensive gastropothy has evident effect, which has become the important means to improve the effective rate and living standard of the patients, which is worthy of promotion.
出处
《中国医药指南》
2016年第15期23-24,共2页
Guide of China Medicine
关键词
肝硬化门脉高压性胃病
普萘洛尔
常规疗法
有效率
临床指征
Cirrhosis and portal hypertensive gastropothy
Propranolol
Conventional therapy
Effective rate
Clinical signs
